164 related articles for article (PubMed ID: 19690669)
41. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
Annaberdyev S; Gibbons J; Hardacre JM
World J Surg Oncol; 2009 Mar; 7():30. PubMed ID: 19291285
[TBL] [Abstract][Full Text] [Related]
42. [Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case].
Baldo S; Rivoire M; Sobrero A; Comandini D; Civalleri D; Stella M; Quaglia F; Santoni R; Malerba M; Mariani F; DeCian F
Suppl Tumori; 2005; 4(3):S97. PubMed ID: 16437930
[TBL] [Abstract][Full Text] [Related]
43. [Three cases of giant rectal gastrointestinal stromal tumor].
Nakamoto K; Nagahara H; Noda E; Inoue T; Maeda K; Ohira G; Amano R; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1984-6. PubMed ID: 22202260
[TBL] [Abstract][Full Text] [Related]
44. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.
Yanagawa S; Tanabe K; Suzuki T; Tokumoto N; Arihiro K; Ohdan H
World J Surg Oncol; 2014 Feb; 12():47. PubMed ID: 24575748
[TBL] [Abstract][Full Text] [Related]
45. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
[TBL] [Abstract][Full Text] [Related]
46. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in therapy for gastrointestinal stromal tumors.
Maki RG
Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
[TBL] [Abstract][Full Text] [Related]
48. The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.
Staiger WI; Ronellenfitsch U; Kaehler G; Schildhaus HU; Dimitrakopoulou-Strauss A; Schwarzbach MH; Hohenberger P
World J Surg Oncol; 2008 Apr; 6():37. PubMed ID: 18394167
[TBL] [Abstract][Full Text] [Related]
49. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
J Cancer Res Ther; 2011; 7(4):491-3. PubMed ID: 22269418
[No Abstract] [Full Text] [Related]
50. Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib.
Emoto S; Akiyoshi T; Mukai T; Yamaguchi T; Nagasaki T; Konishi T; Fukunaga Y
J Gastrointest Surg; 2021 Nov; 25(11):2963-2965. PubMed ID: 33948860
[No Abstract] [Full Text] [Related]
51. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy.
Wang CM; Fu H; Zhao GF; Wang J; Shi YQ
Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980
[No Abstract] [Full Text] [Related]
52. Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.
Eisenberg BL
Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S24-9. PubMed ID: 17101065
[TBL] [Abstract][Full Text] [Related]
53. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
[TBL] [Abstract][Full Text] [Related]
54. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
[TBL] [Abstract][Full Text] [Related]
55. Gastrointestinal stromal tumors: current management.
Pisters PW; Patel SR
J Surg Oncol; 2010 Oct; 102(5):530-8. PubMed ID: 20063363
[TBL] [Abstract][Full Text] [Related]
56. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
Ulusan S; Koç Z; Kayaselçuk F
Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
[TBL] [Abstract][Full Text] [Related]
57. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
Rediti M; Pellegrini E; Molinara E; Cerullo C; Fonte C; Lunghi A; Iori A; Neri B
Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
[TBL] [Abstract][Full Text] [Related]
58. Follow up of patient with totally resected gastric stromal tumor.
Tzilves D; Moschos J; Paikos D; Katsos I; Tarpagos A
Indian J Gastroenterol; 2006; 25(1):47-8; author reply 48. PubMed ID: 16567904
[No Abstract] [Full Text] [Related]
59. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
[No Abstract] [Full Text] [Related]
60. Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.
Ebihara Y; Okushiba S; Kawarada Y; Kitashiro S; Katoh H; Kondo S
Surg Today; 2008; 38(2):174-7. PubMed ID: 18239881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
